http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2074719-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_315ae544538aaeac6d1f4eed6754e4bb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate | 1989-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49faa175658a7a921410be87677393fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78290d7c6889a3a4eb25830511e386cf |
| publicationDate | 1997-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2074719-C1 |
| titleOfInvention | Method of mammalian tumor cell destruction and pharmaceutical composition for mammalian tumor cells destruction |
| abstract | FIELD: medicine, oncology. SUBSTANCE: mammary tumor cells were treated by light and specific inhibitor of enzymatic conversion of protoporphyrinogen to protoporphyrin-IX catalyzed by protoporphyrin oxidase in the presence of porphyrin. Method involves the use of pharmaceutical composition containing specific inhibitor of enzymatic conversion of protoporphyrinogen to protoporphyrin-IX catalyzed by protoporphyrin oxidase. Index I 50 for protoporphyrin oxidase is less 1 mcM and negative reductive-oxidizing potential is above -500 mV. EFFECT: improved method of tumor cells destruction. 11 cl, 5 tbl, 1 dwg |
| priorityDate | 1988-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.